Chartered Management Institute

FEBRUARY 26, 2024

Since founding the Human Diver in 2016, Gareth has given risk training to a wide variety of organisations, from oil and gas and construction to pharmaceuticals and software. In all sectors, tensions exist between competing pressures such as resources, finance, time and workload.

Uncertainty 52

Uncertainty Risk Management Training Learning-by-Doing 52

Strategy Driven

JULY 13, 2011

Value: The Four Cornerstones of Corporate Finance by Tim Koller. While you can find numerous books focused on the topic of corporate finance, few offer the type of information managers need to help them make important decisions day in and day out. Discusses the four foundational principles of corporate finance.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. FREE StrategyDriven Trial Membership.

Tactics 51

Tactics Execution Pharmaceuticals Human Capital 51

Coaching Tip

AUGUST 31, 2011

Even if the government had the deep pockets to finance our recovery, it’s a national shame that Washington, D.C. Al Weatherhead is the author of The Power of Adversity and chairman and CEO of Weatherchem, a private manufacturer of plastic closures for food, spice, pharmaceutical and nutraceutical products.

Pharmaceuticals 90

Pharmaceuticals Uncertainty Power Long-term 90

Harvard Business Review

OCTOBER 26, 2011

Solyndra's example has been particularly stark: it raised over $1 billion in equity finance in addition to receiving a $535 million loan guarantee from the Department of Energy, all prior to a cancelled IPO and the recent FBI investigation upon its bankruptcy.

Energy 13

Energy Finance IPO Biotechnology 13

Strategy Driven

JANUARY 5, 2020

One such example is that of a large Swiss-based pharmaceutical company that invested around $11.3 Private businesses with pension funds have increased their commodities investment, especially through Exchange-traded funding. billion in platinum and other metals as well.

Price 66

Price Short-term Long-term Globalization 66

Harvard Business Review

AUGUST 8, 2018

As chief executive from 1972 to 1994, Richard Gelb (HBS, 1950) orchestrated Bristol-Myers’ acquisition of Squibb and transformed the firm from a personal care company to a diversified pharmaceutical giant. In another supplementary analysis, we used the rankings of finance departments in business schools.

Influence 13

Influence Education Pharmaceuticals Finance 13

Harvard Business Review

APRIL 23, 2012

Supreme Court is expected to rule on whether the work done by pharmaceutical salespeople really counts as "selling." pharmaceutical industry could face billions in retroactive overtime. By any reasonable definition, pharmaceutical salespeople are absolutely salespeople. Pharmaceutical companies measure territory sales results.

Pharmaceuticals 15

Pharmaceuticals Banking Objective Incentives 15

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement. The largest payments were from Pfizer ($2.3 billion) and GlaxoSmithKline ($3 billion).

Finance 9

Finance Banking Press Release Pharmaceuticals 9

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others. Economy Entrepreneurship Finance'

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Entrepreneur 11

Harvard Business Review

JUNE 9, 2017

Equally troublesome, almost all policies focus exclusively on payments and finances but ignore the powerful influence of careerism and other non-financial motives that may compromise objectivity far more than financial incentives. For academics, publishing and obtaining grants are key to promotion and career advancement.

Conflict of Interest 10

Conflict of Interest Pharmaceuticals Policies Industry 10

Harvard Business Review

APRIL 16, 2012

This raises the question of whether retaining strategic cash makes economic sense and should be viewed as a legitimate corporate finance tool in today's environment. Strategic cash also can be used to finance long-term reinvestment programs in the business—which is especially valuable to companies in capital-intensive industries (e.g.,

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

OCTOBER 13, 2011

The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk. Here, the protocols from other industries can provide some insight.

Banking 13

Banking Pharmaceuticals Microfinance Risk Management 13

Harvard Business Review

AUGUST 3, 2012

Although many analysts and even executives have stated that established pharmaceutical firms are cutting their R&D budgets, the fact is that ongoing R&D expenditures on internal projects remain just as high in 2011 and 2012 as they have for the past decade — and those levels are historical highs.

Licensing 14

Licensing Depreciation Pharmaceuticals Budgeting 14

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. It also took into account their roles in changing patient behavior.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

AUGUST 29, 2011

There's a sense that a woman is just working until she gets married, [that] she is not a long-term resource," said one senior finance professional. Women are critical contributors in finance, info-tech, pharmaceutical research, and other industries that are driving the growth of India Inc. We do all of them.".

Stress 16

Stress Human Resources Pharmaceuticals Finance 16

Harvard Business Review

OCTOBER 20, 2016

Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988. pharmaceutical company, had to abandon its $106 billion attempt to buy British drug maker AstraZeneca in the face of opposition from UK politicians. This year, for example, the U.S.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

JUNE 29, 2015

If you ask someone who works in finance (as I had to) about PE and innovation, he or she will likely tell you that PE sponsors aren’t looking for the next big thing—they’re looking for companies that are dominant in a market, aren’t risky, and have a predictable and steady stream of cash to pay back debt.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

JULY 4, 2017

One way to appeal to this demographic (and to the parents who often finance young drivers’ transportation) is to focus on safety. Think of the ultimate home office with printers, a desk, and video conference abilities so pharmaceutical reps and traveling sales people don’t have to squat at Panera or Starbucks all day.

Transportation 10

Transportation Sports Pharmaceuticals Health Care 10

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 14

COO Sample Telecommunications Automotive 14

Harvard Business Review

FEBRUARY 23, 2011

The first part of the conference's message, that the infrastructure of the continent is greatly wanting, was a topic of many panels, including a pair of engaging ones on technology, but it was brought home most vividly in another context, by Thierry Tanoh , a vice president at the International Finance Corp.

Conference 14

Conference Pharmaceuticals Politics Entrepreneur 14

Harvard Business Review

OCTOBER 25, 2018

The superstars tend to be more involved in global flows of trade and finance, more digitally mature, and they dominate the lists of the most valued companies, the most valued brands, the most desirable places to work, and the most innovative companies.

Industry 13

Industry Company GDP Bottom-up 13

Harvard Business Review

NOVEMBER 20, 2015

One result is that they keep their cards close to their chests about what they are looking for (at first), while expecting you to reveal everything – your finances, pricing, ownership, human resources, production processes, quality assurance, customer service procedures, KPIs, and existing customers.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MAY 26, 2014

Top-tier thinkers from data science, business, finance, and the digital world are coming together to find new solutions. New players are fearlessly sensing the opportunity. Health care is attracting an influx of talent from other industries to tackle some of its toughest problems.

Health Care 8

Health Care Venture Funding Entrepreneur Pharmaceuticals 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Carmakers have started using 3D technology to produce parts. And last year saw the first demonstration of a digital printer producing multilayer, standards-based circuit boards.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. In these cases, running the numbers and grasping what they tell you is important, but it isn’t enough. With gray area problems, you have to look hard at the economics and look past the economics. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

MARCH 14, 2017

In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers. ” Meanwhile, the company recruited non-scientist talent from finance, consulting, tech, academia, and political campaigns and inserted them into drug-development roles.

Innovation 10

Innovation Company Incentives Industry 10

Harvard Business Review

SEPTEMBER 10, 2013

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. Finance Innovation' Executing on Innovation An HBR Insight Center. Innovation Isn''t an Idea Problem.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. Finance Innovation Insight Center_Innovation no-intromercial' Innovation Isn’t an Idea Problem.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. "Follow us here for updates on our work, our research, and our people.".

Compliance 15

Compliance Media Compliance Officer Policies 15

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JUNE 16, 2016

Pharmaceutical companies spend millions upon millions preparing meticulous plans for new drug launches – and yet their route-to-market strategies haven’t changed in decades, even though the reality of the market has. The failure stemmed from resistance in the U.S. What builds management perspectives?

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

NOVEMBER 10, 2017

In one pharmaceutical R&D company, we identified three critical populations that needed to change to enable the execution of the organization’s strategy. Every organization has functions that wield a disproportionate amount of power — the typical suspects are finance, procurement, and audit. Insight center.

Skills 11

Skills Agility Learning-by-Doing Content 11

Harvard Business Review

AUGUST 6, 2015

I made a career switch seven years ago, when I went from working as a reporter at the Financial Times , where I covered health care in the United States, to consulting — advising CEOs in the pharmaceutical industry on thought leadership and articulating their corporate strategies. Consider the legal field.

Career 8

Career Skills Health Care Pharmaceuticals 8